Statera BioPharma (STU:7CB) Total Equity: €-10.27 Mil (As of Sep. 2022)


What is Statera BioPharma Total Equity?

Statera BioPharma STU:7CB 20 Total Equity is €-10.27 Mil as of Sep. 2022. GuruFocus rates STU:7CB with a GF Score™ of 20/100. The stock has 1 warning sign investors should review.

Statera BioPharma's total equity for the quarter that ended in Sep. 2022 was €-10.27 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Statera BioPharma Total Equity Historical Data

* Premium members only.

The historical data trend for Statera BioPharma's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Statera BioPharma Total Equity Chart

Statera BioPharma Annual Data
Trend Dec19 Dec20 Dec21
Total Equity
-3.79 -3.01 -1.33

Statera BioPharma Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 63.07 -1.33 -2.21 -6.55 -10.27

Statera BioPharma Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Statera BioPharma's Total Equity for the fiscal year that ended in Dec. 2021 is calculated as

Total Equity=Total Assets(Q: Dec. 2021 )-Total Liabilities(Q: Dec. 2021 )
=18.735-20.068
=-1.33

Statera BioPharma's Total Equity for the quarter that ended in Sep. 2022 is calculated as

Total Equity=Total Assets(Q: Sep. 2022 )-Total Liabilities(Q: Sep. 2022 )
=12.876-23.146
=-10.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of €-10.27 Mil mean?
Statera BioPharma (STU:7CB) has a Total Equity of €-10.27 Mil as of Sep. 2022. The total amount of equity as record on a company's balance sheet. View historical data for Statera BioPharma and its competitors.
Is Statera BioPharma's Total Equity too high?
Statera BioPharma's current Total Equity is €-10.27 Mil. Overall, Statera BioPharma has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Statera BioPharma's Total Equity compare to NRBO and PALI?
Statera BioPharma's Total Equity of €-10.27 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Statera BioPharma and its competitors. Statera BioPharma's current Total Equity is €-10.27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Statera BioPharma stock overvalued right now?
Statera BioPharma (STU:7CB) has a current Total Equity of €-10.27 Mil. The current Total Equity is €-10.27 Mil. Statera BioPharma's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Statera BioPharma (STU:7CB), the current Total Equity is €-10.27 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Statera BioPharma Business Description

Address 2580 East Harmony Road, Suite 316, Fort Collins, CO, USA, 80528
Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction. Its proprietary platform of Toll-like receptor drug candidates has applications in mitigation of radiation injury, mitigation of T-cell exhaustion, inflammation, T-cell exhaustion, immune system dysfunction, oncology, infection and neutropenia.